We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

Yale University to Establish a Center For Cannabis Research

The Yale Center for the Science of Cannabis and Cannabinoids will foster studies into the acute and chronic effects of cannabinoids on neuronal and mental health.

Read More

No Link Between Legal Cannabis and Psychosis Diagnoses, Study Finds

Legalizing cannabis does not affect psychosis diagnoses or the prescription of antipsychotic medicines, a new study published in JAMA Network Open has found.

Read More

Colorado Regulator Issues Warning About Moldy Flower

State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in a batch of cannabis flower.

Read More

Oregon Regulator Recalls 1,000 Cannabis Vapes

The products had tested positive for two pesticides, piperonyl butoxide and a pyrethrin.

Read More

FDA Defers to Congress For CBD Food and Supplement Regulations

The federal agency made its decision following a “careful review” of the potential regulatory pathways of CBD products in the US.

Read More

Demand for Codeine Plummets Where Cannabis is Legalized, Study Finds

States that legalize recreational cannabis use also see a reduction in demand for prescription codeine, according to a new study.

Read More

Nevada Cannabis Regulator Suspends Cultivator

A cannabis cultivation company in Nevada has lost its license after its staff were seen to be diverting cannabis from its facility.

Read More

Kaycha Labs Becomes First New York Cannabis Lab to Perform Every Approved Test

Kaycha Labs is the first of seven state-certified labs to be cleared by the NY regulator to carry out all nine types of test.

Read More

The FDA Issues Guidance For Cannabis Research

This guidance outlines the FDA’s “current thinking” on topics relevant to clinical research related to the development of human drugs containing cannabis or cannabis-derived compounds.

Read More

 
Advertisement